• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

妊娠期淋巴瘤的临床特征、处理和结局:澳大拉西亚淋巴瘤联盟的一项多中心研究。

The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance.

机构信息

Sydney Adventist Hospital, Wahroonga, New South Wales, Australia.

College of Health and Medicine, Australian National University, Canberra, Australian Capital Territory, Australia.

出版信息

Br J Haematol. 2023 Jun;201(5):887-896. doi: 10.1111/bjh.18727. Epub 2023 Mar 7.

DOI:10.1111/bjh.18727
PMID:36880558
Abstract

Lymphoma in pregnancy (LIP) presents unique clinical, social and ethical challenges; however, the evidence regarding this clinical scenario is limited. We conducted a multicentre retrospective observational study reporting on the features, management, and outcomes of LIP in patients diagnosed between January 2009 and December 2020 at 16 sites in Australia and New Zealand for the first time. We included diagnoses occurring either during pregnancy or within the first 12 months following delivery. A total of 73 patients were included, 41 diagnosed antenatally (AN cohort) and 32 postnatally (PN cohort). The most common diagnoses were Hodgkin lymphoma (HL; 40 patients), diffuse large B-cell lymphoma (DLBCL; 11) and primary mediastinal B-cell lymphoma (PMBCL; six). At a median follow up of 2.37 years, the 2- and 5-year overall survival (OS) for patients with HL were 91% and 82%. For the combined DLBCL and PMBCL group, the 2-year OS was 92%. Standard curative chemotherapy regimens were successfully delivered to 64% of women in the AN cohort; however, counselling regarding future fertility and termination of pregnancy were suboptimal, and a standardised approach to staging lacking. Neonatal outcomes were generally favourable. We present a large multicentre cohort of LIP reflecting contemporary practice and identify areas in need of ongoing research.

摘要

妊娠合并淋巴瘤(LIP)呈现出独特的临床、社会和伦理挑战;然而,关于这一临床情况的证据有限。我们首次在澳大利亚和新西兰的 16 个地点进行了一项多中心回顾性观察研究,报告了 2009 年 1 月至 2020 年 12 月期间诊断出的 LIP 患者的特征、管理和结局。我们纳入了在妊娠期间或分娩后 12 个月内诊断出的病例。共纳入了 73 例患者,其中 41 例在产前(AN 队列)诊断,32 例在产后(PN 队列)诊断。最常见的诊断是霍奇金淋巴瘤(HL;40 例)、弥漫性大 B 细胞淋巴瘤(DLBCL;11 例)和原发性纵隔 B 细胞淋巴瘤(PMBCL;6 例)。在中位随访 2.37 年后,HL 患者的 2 年和 5 年总生存率(OS)分别为 91%和 82%。对于合并的 DLBCL 和 PMBCL 组,2 年 OS 为 92%。在 AN 队列中,64%的女性成功接受了标准的治愈性化疗方案;然而,关于未来生育能力和终止妊娠的咨询并不理想,且缺乏标准化的分期方法。新生儿结局通常较好。我们呈现了一个大型的多中心 LIP 队列,反映了当代实践,并确定了需要持续研究的领域。

相似文献

1
The clinical features, management and outcomes of lymphoma in pregnancy: A multicentre study by the Australasian Lymphoma Alliance.妊娠期淋巴瘤的临床特征、处理和结局:澳大拉西亚淋巴瘤联盟的一项多中心研究。
Br J Haematol. 2023 Jun;201(5):887-896. doi: 10.1111/bjh.18727. Epub 2023 Mar 7.
2
Role of consolidative radiation therapy for patients with mediastinal diffuse large B-cell lymphoma in the rituximab era.巩固性放射治疗在利妥昔单抗时代对纵隔弥漫性大B细胞淋巴瘤患者的作用。
J Cancer Res Ther. 2018 Oct-Dec;14(6):1397-1402. doi: 10.4103/jcrt.JCRT_3_17.
3
Primary Mediastinal B-Cell Lymphoma in Children and Young Adults.儿童和青年原发性纵隔B细胞淋巴瘤
J Natl Compr Canc Netw. 2023 Mar;21(3):323-330. doi: 10.6004/jnccn.2023.7004.
4
Favorable outcome of primary mediastinal large B-cell lymphoma in a single institution: the British Columbia experience.单机构原发性纵隔大B细胞淋巴瘤的良好预后:不列颠哥伦比亚省的经验
Ann Oncol. 2006 Jan;17(1):123-30. doi: 10.1093/annonc/mdj030. Epub 2005 Oct 19.
5
Non-Hodgkin lymphomas: impact of rituximab on overall survival of patients with diffuse large B-cell and follicular lymphoma.非霍奇金淋巴瘤:利妥昔单抗对弥漫性大 B 细胞淋巴瘤和滤泡性淋巴瘤患者总生存的影响。
Arch Med Res. 2015 Aug;46(6):454-61. doi: 10.1016/j.arcmed.2015.07.004. Epub 2015 Jul 31.
6
Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy.80例孕期诊断为非霍奇金淋巴瘤患者的母婴结局:来自国际癌症、不孕与妊娠网络的结果
Br J Haematol. 2021 Apr;193(1):52-62. doi: 10.1111/bjh.17103. Epub 2020 Sep 18.
7
Maternal and Fetal Outcomes After Therapy for Hodgkin or Non-Hodgkin Lymphoma Diagnosed During Pregnancy.妊娠期诊断的霍奇金或非霍奇金淋巴瘤治疗后的母婴结局。
JAMA Oncol. 2016 Aug 1;2(8):1065-9. doi: 10.1001/jamaoncol.2016.1396.
8
Prognostic factors, therapeutic approaches, and distinct immunobiologic features in patients with primary mediastinal large B-cell lymphoma on long-term follow-up.长期随访的原发性纵隔大 B 细胞淋巴瘤患者的预后因素、治疗方法和独特的免疫生物学特征。
Blood Cancer J. 2020 May 4;10(5):49. doi: 10.1038/s41408-020-0312-7.
9
Outcomes of human immunodeficiency virus-associated Burkitt lymphoma and diffuse large B-cell lymphoma treated in Australia: A report from the Australasian Lymphoma Alliance.澳大利亚治疗人类免疫缺陷病毒相关性伯基特淋巴瘤和弥漫性大 B 细胞淋巴瘤的结果:来自澳大利亚淋巴瘤联盟的报告。
Br J Haematol. 2023 Jun;201(5):865-873. doi: 10.1111/bjh.18704. Epub 2023 Mar 3.
10
Clinical prognostic factors of diffuse large B cell non-Hodgkin lymphoma: a retrospective study.弥漫性大B细胞非霍奇金淋巴瘤的临床预后因素:一项回顾性研究。
J Egypt Natl Canc Inst. 2011 Mar;23(1):17-24. doi: 10.1016/j.jnci.2011.07.003. Epub 2011 Sep 8.

引用本文的文献

1
Haematological malignancies during pregnancy: a systematic review of necessary services in the Australian context.孕期血液系统恶性肿瘤:澳大利亚背景下必要服务的系统评价
Intern Med J. 2025 Mar;55(3):393-406. doi: 10.1111/imj.16651. Epub 2025 Mar 5.